The article discusses the use of ristocetin cofactor and immunotubidometric assays in determining discrepancy in von Willebrand factor activity. Topics covered include the analysis of the binding activity of the factor. Also mentioned is the prevalence of anti-animal antibodies in blood transfusion recipients.